Pharmacological effects of a combination of fenoterol hydrobromide and ipratropium bromide.
The bronchospasmolytic and cardiovascular effects of fenoterol hydrobromide and ipratropium bromide alone and in combination were investigated using metered aerosols in guinea pigs and dogs and intravenous injection in dogs. The additive effect of the combination on bronchospasmolysis could be demonstrated. The slight cardiovascular side-effects of fenoterol hydrobromide alone were reduced to an insignificant level with the combination administered as a metered aerosol, but were still present when the combination was administered parenterally. Ipratropium bromide in both forms of administration had no effect on the cardiovascular system.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000280:Administration, Inhalation; D000403:Airway Resistance / Q000187:drug effects*; D000818:Animals; D001286:Atropine Derivatives / Q000494:pharmacology*; D004285:Dogs; D004338:Drug Combinations; D004357:Drug Synergism; D005280:Fenoterol / Q000494:pharmacology*; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D007275:Injections, Intravenous; D009241:Ipratropium / Q000494:pharmacology*
D001286:Atropine Derivatives; D004338:Drug Combinations; D005280:Fenoterol; D009241:Ipratropium; D000109:Acetylcholine